Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

6ea03bc22310ede262fc8192ea07859d408c9061c213e514fb096ea79c33d156

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable, Net (USD, thousands)

Inventory, Net (USD, thousands)

Prepaid Expenses and Other Current Assets (USD, thousands)

Total Current Assets (USD, thousands)

Property and Equipment, Net (USD, thousands)

Operating Lease Right-of-Use Assets (USD, thousands)

Other Non-Current Assets (USD, thousands)

Total Assets (USD, thousands)

Accounts Payable (USD, thousands)

Accrued Expenses (USD, thousands)

Other Current Liability (USD, thousands)

Total Current Liabilities (USD, thousands)

Total Liabilities (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

Accumulated Other Comprehensive Loss (USD, thousands)

Accumulated Deficit (USD, thousands)

Total Stockholders’ Equity (USD, thousands)

Total Liabilities, Preferred Stock and Stockholders’ Equity (USD, thousands)

d8eed122f1c9aa3f911e90fcdba96daff93e6ef7fe1e0b6a6d775ec11da73008

Net Loss (USD, thousands)

Stock-based Compensation Expense (USD, thousands)

Amortization of Operating Lease Right-of-Use Assets (USD, thousands)

Net Cash Used in Operating Activities (USD, thousands)

Purchases of Property and Equipment (USD, thousands)

Net Cash (Used in) Provided by Investing Activities (USD, thousands)

Proceeds from Exercises of Stock Options (USD, thousands)

Proceeds from Issuance of Common Stock under the Employee Stock Purchase Plan (USD, thousands)

Proceeds from Issuance of Common Stock, Net of Issuance Costs (USD, thousands)

Payments for Offering Costs (USD, thousands)

Net Cash Provided by Financing Activities (USD, thousands)

Net (Decrease) Increase in Cash and Cash Equivalents (USD, thousands)

Cash and Cash Equivalents at Beginning of Period (USD, thousands)

Cash and Cash Equivalents at End of Period (USD, thousands)

bbd838bdcee3b37b5f895e17b44a751c0cee532bd5a0821c705334312ca7cd49

Research and Development Expenses (USD, thousands)

Selling, General and Administrative Expenses (USD, thousands)

Loss from Operations (USD, thousands)

Other Income (USD, thousands)

Total Other Income (USD, thousands)

Unrealized Gain (Loss) on Available-for-Sale Securities, Net of Tax (USD, thousands)

Comprehensive Loss (USD, thousands)

Net Loss per Share Attributable to Common Stockholders, Basic and Diluted (USD)

de44ba99ddd4b95e3f0b88c28623427dca5f2f38fb4740dafddb2dd3f004ae5c

Current Assets (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Short-term Debt (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

b2376b597aba1a9da00516a7bbb3b06a335f7e5172c0edfeb0ec1404578dcde9

Total Revenue (USD)

Cost of Goods Sold (COGS) (USD)

Selling, General, and Administrative Expenses (SG&A) (USD)

Research and Development (R&D) (USD)

Depreciation and Amortization (D&A) (USD)

Interest Expense (USD)

Operating Income (EBIT) (USD)

Net Income (USD)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

9e85ca852b94e3f339467e345ead4aca43dcb4248efecceeae02e6dee578e5e1

Product Revenue

- PEMGARDA

Total Revenue

89986028df4093132c30ade479915e12a43510698e8c697ed38c424f5817cf96

Invivyd Inc (IVVD)

Financials